Gator Pharms

Gator Pharmaceuticals is a pre-clinical stage biotechnology company based in Alachua, Florida, specializing in the discovery of small molecule therapeutics for oncology, infectious diseases, and inflammatory conditions. The company utilizes a proprietary structural biology and computational docking platform to identify novel binding sites on validated targets, enabling the design of highly specific drug candidates. Their primary research programs include the development of ACE2 inhibitors to prevent viral entry of SARS-CoV-2 and the modulation of the CD24/Siglec-10 immune checkpoint pathway to enhance anti-tumor immunity. Founded by researchers from the University of Florida, Gator Pharmaceuticals focuses on translating academic structural insights into innovative clinical-stage therapies.